Search
Apimeds Pharmaceuticals US Inc
APUSAdd to Watchlist
5.150USD
+0.230+4.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
64.77MMarket Cap
LossP/E TTM
More Details of Apimeds Pharmaceuticals US Inc Company
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Apimeds Pharmaceuticals US Inc Info
Ticker SymbolAPUS
Company nameApimeds Pharmaceuticals US Inc
IPO dateMay 09, 2025
CEOMenon (Vin)
Number of employees2
Security typeOrdinary Share
Fiscal year-endMay 09
Address100 Matawan Road
CityMATAWAN
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code07747
Phone18482015010
Websitehttps://www.apimedsus.com/
Ticker SymbolAPUS
IPO dateMay 09, 2025
CEOMenon (Vin)
Company Executives of Apimeds Pharmaceuticals US Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President, Director
President, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
615.38K
-4.63%
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
Vin Menon
Vin Menon
Chief Executive Officer, Director - Designee
Chief Executive Officer, Director - Designee
--
--
Mr. Amir Dossal
Mr. Amir Dossal
Director - Designee
Director - Designee
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President, Director
President, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
615.38K
-4.63%
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
FAQs
Who are the top five shareholders of Apimeds Pharmaceuticals US Inc?
The top five shareholders of Apimeds Pharmaceuticals US Inc are: Mr. Erik C. Emerson